In MDM2-amplified cell lines, RG7112 restored p53 activity, crossed the blood–brain and the blood–tumor barrier and treatment of MDM2-amplified TP53 wild-type xenografts with the inhibitor reduced tumor growth and increased animal survival [117]. Here, TP53 is linked to neoplasm.